Issue navigation
Volume 41, Issue Supplement_3, August 2005
Supplement Articles
Tumor Necrosis Factor and Chemokine Interactions in the Formation and Maintenance of Granulomas in Tuberculosis
Clinical Infectious Diseases, Volume 41, Issue Supplement_3, August 2005, Pages S189–S193, https://doi.org/10.1086/429994
Reactivation of Latent Granulomatous Infections by Infliximab
Clinical Infectious Diseases, Volume 41, Issue Supplement_3, August 2005, Pages S194–S198, https://doi.org/10.1086/429996
Tumor Necrosis Factor and Its Blockade in Granulomatous Infections: Differential Modes of Action of Infliximab and Etanercept?
Clinical Infectious Diseases, Volume 41, Issue Supplement_3, August 2005, Pages S199–S203, https://doi.org/10.1086/429998
Modulation of Infection with Histoplasma capsulatum by Inhibition of Tumor Necrosis Factor–α Activity
Clinical Infectious Diseases, Volume 41, Issue Supplement_3, August 2005, Pages S204–S207, https://doi.org/10.1086/429999
Tumor Necrosis Factor Inhibition and Invasive Fungal Infections
Clinical Infectious Diseases, Volume 41, Issue Supplement_3, August 2005, Pages S208–S212, https://doi.org/10.1086/430000
Defective Innate Antibacterial Host Responses during Murine Klebsiella pneumoniae Bacteremia: Tumor Necrosis Factor (TNF) Receptor 1 Deficiency versus Therapy with Anti–TNF-α
Clinical Infectious Diseases, Volume 41, Issue Supplement_3, August 2005, Pages S213–S217, https://doi.org/10.1086/430126
Introduction
Tumor Necrosis Factor Inhibition and Opportunistic Infections
Clinical Infectious Diseases, Volume 41, Issue Supplement_3, August 2005, Pages S187–S188, https://doi.org/10.1086/429992
